The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease
Davies Adeloye,Omer Elneima,Luke Daines,Krisnah Poinasamy,Jennifer K Quint,Samantha Walker,Chris E Brightling,Salman Siddiqui,John R Hurst,James D Chalmers,Paul E Pfeffer,Petr Novotny,Thomas M Drake,Liam G Heaney,Igor Rudan,Aziz Sheikh,Anthony De Soyza,International COVID-19 Airways Diseases Group,Mohammad Abdollahi,Dhiraj Agarwal,Riyad Al-Lehebi,Peter J Barnes,Jagadeesh Bayry,Marcel Bonay,Louis J Bont,Arnaud Bourdin,Thomas Brown,Gaetano Caramori,Amy Hai Yan Chan,David H Dockrell,Simon Doe,Jamie Duckers,Anthony D'Urzo,Magnus Ekström,Cristóbal Esteban,Catherine M Greene,Atul Gupta,Jennifer L Ingram,Ee Ming Khoo,Fanny Wai San Ko,Gerard H Koppelman,Brian J Lipworth,Karin Lisspers,Michael Loebinger,Jose Luis Lopez-Campos,Matthew Maddocks,David Mannino,Miguel A Martinez-Garcia,Renae Mcnamara,Marc Miravitlles,Pisirai Ndarukwa,Alison Pooler,Chin Kook Rhee,Peter Schwarz,Dominick Shaw,Michael Steiner,Andrew Tai,Charlotte Suppli Ulrik,Paul Walker,Michelle C Williams
DOI: https://doi.org/10.1016/S2213-2600(21)00286-1
Abstract:Persistent ill health after acute COVID-19-referred to as long COVID, the post-acute COVID-19 syndrome, or the post-COVID-19 condition-has emerged as a major concern. We undertook an international consensus exercise to identify research priorities with the aim of understanding the long-term effects of acute COVID-19, with a focus on people with pre-existing airways disease and the occurrence of new-onset airways disease and associated symptoms. 202 international experts were invited to submit a minimum of three research ideas. After a two-phase internal review process, a final list of 98 research topics was scored by 48 experts. Patients with pre-existing or post-COVID-19 airways disease contributed to the exercise by weighting selected criteria. The highest-ranked research idea focused on investigation of the relationship between prognostic scores at hospital admission and morbidity at 3 months and 12 months after hospital discharge in patients with and without pre-existing airways disease. High priority was also assigned to comparisons of the prevalence and severity of post-COVID-19 fatigue, sarcopenia, anxiety, depression, and risk of future cardiovascular complications in patients with and without pre-existing airways disease. Our approach has enabled development of a set of priorities that could inform future research studies and funding decisions. This prioritisation process could also be adapted to other, non-respiratory aspects of long COVID.